Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-04 Sale |
2023-01-05 8:26 pm |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
2,368 | $5.5238 | $13,080 | 102,420 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-05 8:25 pm |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
1,445 | $10.61 | $15,334 | 88,555 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-26 Option Award |
2024-06-28 4:05 pm |
N/A 2034-06-26 |
Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:54 pm |
N/A 2033-06-14 |
Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:26 pm |
N/A 2033-01-03 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
66,900 | $0 | 102,420 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 07:30 am |
N/A 2032-06-08 |
Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 5:20 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
2,000 | $4.17 | 95,888 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 5:20 pm |
N/A 2026-05-10 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
2,333 | $0 | 95,888 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 5:20 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
333 | $3.72 | 95,888 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:25 pm |
N/A 2032-01-03 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
65,000 | $0 | 88,555 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-15 4:24 pm |
N/A 2031-07-14 |
Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 4:54 pm |
N/A 2025-12-21 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
3,000 | $0 | 25,333 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 4:54 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
3,000 | $3.72 | 25,333 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:25 pm |
N/A 2031-01-04 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
69,000 | $0 | 80,000 (Direct) |
View |